Considerable research efforts showed that the downregulation of MEX3A in bladder cancer could inhibit the proliferation of cells, promote cell apoptosis, thereby exerting a therapeutic effect to inhibit the further deterioration of bladder cancer cells27,28. Here, MEX3A is linked to urinary bladder cancer.